What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His scientific interests lie mostly in Cancer research, Lymphoma, Anaplastic lymphoma kinase, Immunology and Molecular biology.
His Cancer research research is multidisciplinary, relying on both Carcinogenesis, T cell, Anaplastic large-cell lymphoma, Cell cycle and STAT3.
Lymphoma is a primary field of his research addressed under Pathology.
He has researched Anaplastic lymphoma kinase in several fields, including Nucleophosmin, Tyrosine kinase, Receptor Protein-Tyrosine Kinases, Signal transduction and Transfection.
The study incorporates disciplines such as Mutation and Epigenetics in addition to Immunology.
His Molecular biology research integrates issues from Genetics, Gene and Exon.
His most cited work include:
- Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells (850 citations)
- p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. (802 citations)
- BRAF mutations in hairy-cell leukemia (749 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cancer research, Lymphoma, Immunology, Anaplastic lymphoma kinase and Internal medicine.
His biological study spans a wide range of topics, including T cell, Diffuse large B-cell lymphoma, Signal transduction, Anaplastic large-cell lymphoma and Leukemia.
His work carried out in the field of Lymphoma brings together such families of science as Cancer, Genetics and Gene expression profiling.
His Immunology research is multidisciplinary, incorporating elements of Cancer cell, Cytotoxic T cell and Cell culture.
His research in Anaplastic lymphoma kinase intersects with topics in Tyrosine kinase, Crizotinib and PRDM1.
His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Adenocarcinoma.
He most often published in these fields:
- Cancer research (63.55%)
- Lymphoma (41.41%)
- Immunology (27.67%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (63.55%)
- Lymphoma (41.41%)
- Internal medicine (23.47%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Lymphoma, Internal medicine, Oncology and Diffuse large B-cell lymphoma.
His biological study spans a wide range of topics, including Cell culture, B cell, Peripheral T-cell lymphoma, Signal transduction and Anaplastic large-cell lymphoma.
His research in Anaplastic large-cell lymphoma tackles topics such as Anaplastic lymphoma kinase which are related to areas like Small hairpin RNA and RNA interference.
Giorgio Inghirami works mostly in the field of Lymphoma, limiting it down to topics relating to Angioimmunoblastic T-cell lymphoma and, in certain cases, Cancer.
Giorgio Inghirami interconnects CHOP, Febrile neutropenia, Adult Acute Lymphoblastic Leukemia and Minimal residual disease in the investigation of issues within Oncology.
In his research on the topic of Diffuse large B-cell lymphoma, Cell lineage and Vincristine is strongly related with Gene expression.
Between 2017 and 2021, his most popular works were:
- Patient derived organoids to model rare prostate cancer phenotypes (92 citations)
- Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death (86 citations)
- Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death (86 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Giorgio Inghirami mainly focuses on Cancer research, Lymphoma, Internal medicine, Signal transduction and Peripheral T-cell lymphoma.
His Cancer research study combines topics from a wide range of disciplines, such as Pathogenesis, Transcription factor, Transcriptional regulation, B cell and Promoter.
His study of Anaplastic large-cell lymphoma is a part of Lymphoma.
He studied Anaplastic large-cell lymphoma and T-cell lymphoma that intersect with Anaplastic lymphoma kinase and Tyrosine kinase.
Giorgio Inghirami works mostly in the field of Anaplastic lymphoma kinase, limiting it down to topics relating to IRF4 and, in certain cases, Gene expression profiling, as a part of the same area of interest.
His work is dedicated to discovering how Internal medicine, Oncology are connected with Minimal residual disease, Hematology and Early Relapse and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
